CFCThe Compounder Score
TEM logo

TEM — Tempus AI, Inc.

Health Information ServicesHealthcare

$71.60

$-4.29 (-5.65%)

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.

Market Cap

$13.06B

Forward P/E

-1810.4x

52-Week Range

N/A

TEM Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$1.3B

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

-$245M

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

-11.6%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

1.3x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

2.1%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+45.4%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).